CEA-targeted CAR T-cells, which had previously raised concerns over on-target/off-tumor toxicity in colorectal models, demonstrated anti-tumor efficacy when regional delivery strategies were employed to limit systemic exposure [127]. Here, CEACAM5 is linked to neoplasm.